Ontology type: schema:ScholarlyArticle Open Access: True
2016-12
AUTHORSJon Sussex, Yan Feng, Jorge Mestre-Ferrandiz, Michele Pistollato, Marco Hafner, Peter Burridge, Jonathan Grant
ABSTRACTBACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK. METHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements. RESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional £1 of public research expenditure is associated with an additional £0.83-£1.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%. CONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally. More... »
PAGES32
http://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z
DOIhttp://dx.doi.org/10.1186/s12916-016-0564-z
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1011671285
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/26908129
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Applied Economics",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Economics",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomedical Research",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Charities",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Financial Management",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Government",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Health Expenditures",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Models, Econometric",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Private Sector",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Public Sector",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Research",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "United Kingdom",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Office Of Health Economics",
"id": "https://www.grid.ac/institutes/grid.482825.1",
"name": [
"RAND Europe, Cambridge, UK",
"Formerly, Office of Health Economics, London, UK"
],
"type": "Organization"
},
"familyName": "Sussex",
"givenName": "Jon",
"id": "sg:person.01351514340.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351514340.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Office Of Health Economics",
"id": "https://www.grid.ac/institutes/grid.482825.1",
"name": [
"Office of Health Economics, London, UK"
],
"type": "Organization"
},
"familyName": "Feng",
"givenName": "Yan",
"id": "sg:person.0723015016.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723015016.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Office Of Health Economics",
"id": "https://www.grid.ac/institutes/grid.482825.1",
"name": [
"Office of Health Economics, London, UK"
],
"type": "Organization"
},
"familyName": "Mestre-Ferrandiz",
"givenName": "Jorge",
"id": "sg:person.01351556637.67",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351556637.67"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Office Of Health Economics",
"id": "https://www.grid.ac/institutes/grid.482825.1",
"name": [
"Formerly, Office of Health Economics, London, UK"
],
"type": "Organization"
},
"familyName": "Pistollato",
"givenName": "Michele",
"id": "sg:person.0640155570.04",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640155570.04"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "RAND Europe",
"id": "https://www.grid.ac/institutes/grid.425785.9",
"name": [
"RAND Europe, Cambridge, UK"
],
"type": "Organization"
},
"familyName": "Hafner",
"givenName": "Marco",
"id": "sg:person.0756124517.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756124517.33"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of York",
"id": "https://www.grid.ac/institutes/grid.5685.e",
"name": [
"Department of Economics, University of York, Heslington, UK"
],
"type": "Organization"
},
"familyName": "Burridge",
"givenName": "Peter",
"id": "sg:person.07433773763.16",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07433773763.16"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "King's College London",
"id": "https://www.grid.ac/institutes/grid.13097.3c",
"name": [
"Policy Institute at King\u2019s, King\u2019s College London, Strand Campus, WC2R 2LS, London, UK"
],
"type": "Organization"
},
"familyName": "Grant",
"givenName": "Jonathan",
"id": "sg:person.01055471415.15",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055471415.15"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1214/aos/1176346801",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005460302"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1467-9892.1984.tb00381.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006526701"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1741-7015-12-99",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006565540",
"https://doi.org/10.1186/1741-7015-12-99"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0165-1765(97)00214-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006898116"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00191-007-0059-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008662835",
"https://doi.org/10.1007/s00191-007-0059-3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00191-007-0059-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008662835",
"https://doi.org/10.1007/s00191-007-0059-3"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1017/s0266466600012421",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011322255"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1136/amiajnl-2011-000213",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031293266"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1465-7295.1995.tb01847.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031830107"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1465-7295.1995.tb01847.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031830107"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/1467-6451.00067",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042131484"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0304-4076(95)01753-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051002956"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1086/508314",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1058786261"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1086/ipe.1.25056140",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1058907717"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/icc/10.4.975",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1059654576"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1162/0033553041502144",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1063348973"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2307/1913236",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1069640597"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1074965672",
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00191-017-0524-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1091048368",
"https://doi.org/10.1007/s00191-017-0524-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00191-017-0524-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1091048368",
"https://doi.org/10.1007/s00191-017-0524-6"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1017/cbo9780511492327",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1098680657"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/0198774508.001.0001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1098730911"
],
"type": "CreativeWork"
}
],
"datePublished": "2016-12",
"datePublishedReg": "2016-12-01",
"description": "BACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK.\nMETHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements.\nRESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional \u00a31 of public research expenditure is associated with an additional \u00a30.83-\u00a31.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%.\nCONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally.",
"genre": "research_article",
"id": "sg:pub.10.1186/s12916-016-0564-z",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.3560719",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.3957548",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1032885",
"issn": [
"1741-7015"
],
"name": "BMC Medicine",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "14"
}
],
"name": "Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom",
"pagination": "32",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"379baa3a7fe38d157f494cfe7b82668269bc51191479f7b8de2366dea5cf901b"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"26908129"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"101190723"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s12916-016-0564-z"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1011671285"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s12916-016-0564-z",
"https://app.dimensions.ai/details/publication/pub.1011671285"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T19:15",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000549.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1186%2Fs12916-016-0564-z"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'
This table displays all metadata directly associated to this object as RDF triples.
232 TRIPLES
21 PREDICATES
60 URIs
33 LITERALS
21 BLANK NODES